Vanguard Group
AMED

Vanguard Group’s Amedisys AMED Stock Holding History

Vanguard Group’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-3,041,392
Closed -$299M – 4349
2025
Q2 		$299M Sell
3,041,392
-156,119
-5% -$14.8M ﹤0.01% 1309
2025
Q1 		$296M Sell
3,197,511
-18,609
-0.6% -$1.72M 0.01% 1279
2024
Q4 		$292M Buy
3,216,120
+10,817
+0.3% +$993K 0.01% 1357
2024
Q3 		$309M Sell
3,205,303
-22,397
-0.7% -$2.19M 0.01% 1310
2024
Q2 		$296M Buy
3,227,700
+126,922
+4% +$11.8M 0.01% 1266
2024
Q1 		$286M Sell
3,100,778
-117,814
-4% -$11M 0.01% 1303
2023
Q4 		$306M Sell
3,218,592
-22,568
-0.7% -$2.11M 0.01% 1273
2023
Q3 		$303M Buy
3,241,160
+12,137
+0.4% +$1.12M 0.01% 1200
2023
Q2 		$295M Sell
3,229,023
-1,250
-0% -$103K 0.01% 1253
2023
Q1 		$238M Buy
3,230,273
+101,857
+3% +$8.81M 0.01% 1360
2022
Q4 		$261M Buy
3,128,416
+86,389
+3% +$7.79M 0.01% 1273
2022
Q3 		$294M Buy
3,042,027
+10,457
+0.3% +$1.25M 0.01% 1146
2022
Q2 		$319M Sell
3,031,570
-18,592
-0.6% -$2.38M 0.01% 1139
2022
Q1 		$526M Sell
3,050,162
-108,615
-3% -$16.2M 0.01% 927
2021
Q4 		$511M Sell
3,158,777
-61,937
-2% -$9.95M 0.01% 985
2021
Q3 		$480M Buy
3,220,714
+80,322
+3% +$16.7M 0.01% 997
2021
Q2 		$769M Buy
3,140,392
+18,787
+0.6% +$4.93M 0.02% 762
2021
Q1 		$827M Buy
3,121,605
+94,470
+3% +$26.6M 0.02% 703
2020
Q4 		$888M Buy
3,027,135
+79,302
+3% +$20.3M 0.03% 619
2020
Q3 		$697M Sell
2,947,833
-117,317
-4% -$26.7M 0.02% 642
2020
Q2 		$609M Sell
3,065,150
-116,203
-4% -$21.7M 0.02% 675
2020
Q1 		$584M Buy
3,181,353
+40,625
+1% +$7.23M 0.02% 612
2019
Q4 		$524M Sell
3,140,728
-43,387
-1% -$6.45M 0.02% 797
2019
Q3 		$417M Sell
3,184,115
-279,661
-8% -$36.4M 0.02% 886
2019
Q2 		$421M Sell
3,463,776
-144,233
-4% -$17.1M 0.02% 889
2019
Q1 		$445M Sell
3,608,009
-120,026
-3% -$15.1M 0.02% 847
2018
Q4 		$437M Buy
3,728,035
+401,855
+12% +$47.4M 0.02% 768
2018
Q3 		$416M Buy
3,326,180
+415,060
+14% +$45.8M 0.02% 894
2018
Q2 		$249M Buy
2,911,120
+171,661
+6% +$12.6M 0.01% 1204
2018
Q1 		$165M Buy
2,739,459
+37,301
+1% +$2.12M 0.01% 1422
2017
Q4 		$142M Buy
2,702,158
+78,427
+3% +$4.13M 0.01% 1515
2017
Q3 		$147M Buy
2,623,731
+237,685
+10% +$12.6M 0.01% 1477
2017
Q2 		$150M Buy
2,386,046
+16,368
+0.7% +$953K 0.01% 1426
2017
Q1 		$121M Buy
2,369,678
+63,238
+3% +$3.02M 0.01% 1550
2016
Q4 		$98.3M Sell
2,306,440
-522,085
-18% -$22.2M 0.01% 1628
2016
Q3 		$134M Sell
2,828,525
-277,563
-9% -$13.9M 0.01% 1390
2016
Q2 		$157M Buy
3,106,088
+33,785
+1% +$1.71M 0.01% 1209
2016
Q1 		$149M Buy
3,072,303
+277,784
+10% +$10.7M 0.01% 1198
2015
Q4 		$110M Buy
2,794,519
+289,319
+12% +$11.6M 0.01% 1399
2015
Q3 		$95.1M Buy
2,505,200
+399,948
+19% +$16.9M 0.01% 1468
2015
Q2 		$83.6M Sell
2,105,252
-11,996
-0.6% -$374K 0.01% 1637
2015
Q1 		$56.7M Buy
2,117,248
+99,095
+5% +$2.8M ﹤0.01% 1840
2014
Q4 		$59.2M Buy
2,018,153
+44,482
+2% +$1.1M ﹤0.01% 1745
2014
Q3 		$39.8M Sell
1,973,671
-81,475
-4% -$1.57M ﹤0.01% 1920
2014
Q2 		$34.4M Sell
2,055,146
-110,077
-5% -$1.56M ﹤0.01% 2011
2014
Q1 		$32.2M Buy
2,165,223
+250,775
+13% +$3.86M ﹤0.01% 2025
2013
Q4 		$28M Buy
1,914,448
+106,382
+6% +$1.71M ﹤0.01% 2045
2013
Q3 		$31.1M Buy
1,808,066
+70,115
+4% +$1.04M ﹤0.01% 1953
2013
Q2 		$20.2M Buy
+1,737,951
New +$19.9M ﹤0.01% 2065

Other funds holding AMED

Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
MCI
MRP Capital Investments Alpharetta, Georgia $115M AUM 48.08% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Vanguard Group's AMED Position: Q3 2025 in Review

Vanguard Group sold out of Amedisys (AMED) in Q3 2025, closing a stake of 3,041,392 shares — an estimated $299M sold.

Vanguard Group first reported a position in AMED in Q2 2013 and held it in 49 quarters. The position peaked at $888M in Q4 2020. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.

  • Vanguard Group reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
  • Vanguard Group sold 3,041,392 Amedisys shares in Q3 2025, an estimated $299M.
  • Vanguard Group first reported a position in Amedisys in Q2 2013 and held it in 49 quarters.
  • Vanguard Group's Amedisys position peaked at $888M in Q4 2020.
  • 4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.

Based on Vanguard Group's 13F filing for Q3 2025, filed 7 Nov 2025.